Literature DB >> 6819085

Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

G L Shen-Ong, E J Keath, S P Piccoli, M D Cole.   

Abstract

We have found that the myc oncogene has been modified by abortive recombination with the alpha heavy-chain immunoglobulin constant-region (C alpha) gene in five different mouse plasmacytoma lines. Recombination occurred approximately 0.8-2.0 kb to the 5' side of two distinct coding regions, defined by sequence homology between the chicken cellular and plasmacytoma myc genes. The myc and C alpha genes were always in opposite transcriptional orientation, with the recombination site within the C alpha switch region sequences. DNA recombination was found to correlate with the production of a novel 2.1 kb species of myc RNA that was 0.4 kb shorter than the normal cellular transcript. No elevated levels of myc RNA were evident, suggesting that DNA rearrangements have altered the myc oncogene product. This oncogene activation corresponds to the chromosomal translocations found in nearly all plasmacytomas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819085     DOI: 10.1016/0092-8674(82)90137-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  140 in total

1.  Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Authors:  S Mai; J Hanley-Hyde; G J Rainey; T I Kuschak; J T Paul; T D Littlewood; H Mischak; L M Stevens; D W Henderson; J F Mushinski
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Bacterial evolution through the selective loss of beneficial Genes. Trade-offs in expression involving two loci.

Authors:  Erik R Zinser; Dominique Schneider; Michel Blot; Roberto Kolter
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

3.  Cd++ inhibits EGF induced DNA synthesis but not EGF induced myc mRNA accumulation in serum starved NRK-49F cells.

Authors:  N Tang; J A Clapper; M D Enger
Journal:  Cell Biol Toxicol       Date:  1991-01       Impact factor: 6.691

4.  Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.

Authors:  G L Shen-Ong; L Wolff
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

6.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

7.  Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line.

Authors:  D D Sarbassov; R Stefanova; V G Grigoriev; C A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Colocalization of somatic and meiotic double strand breaks near the Myc oncogene on mouse chromosome 15.

Authors:  Siemon H Ng; Sarah A Maas; Petko M Petkov; Kevin D Mills; Kenneth Paigen
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

9.  Chromosome assignments of four mouse cellular homologs of sarcoma and leukemia virus oncogenes.

Authors:  A Y Sakaguchi; P A Lalley; B U Zabel; R W Ellis; E M Scolnick; S L Naylor
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Regional localization of two human cellular Kirsten ras genes on chromosomes 6 and 12.

Authors:  A Y Sakaguchi; B U Zabel; K H Grzeschik; M L Law; R W Ellis; E M Scolnick; S L Naylor
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.